16-30 of 188
Hidden Hunger in CKD: A Case-Based Perspective
Clinician's RoundtableHidden Hunger in CKD: A Case-Based Perspective
Jeanette Andrade, PhD, RDN, LDN, FAND
The Silent Clues Behind IgA Nephropathy Diagnosis
Clinician's RoundtableThe Silent Clues Behind IgA Nephropathy Diagnosis
Abdallah Geara, MD
Rethinking Potassium Restriction in Chronic Kidney Disease Management
Clinician's RoundtableRethinking Potassium Restriction in Chronic Kidney Disease Management
Deborah Clegg, PhD
Dietary Potassium in CKD: Navigating Risks, Sources, and Patient Factors
Clinician's RoundtableDietary Potassium in CKD: Navigating Risks, Sources, and Patient Factors
Deborah Clegg, PhD
Early Detection as a Turning Point in IgA Nephropathy Care
Clinician's RoundtableEarly Detection as a Turning Point in IgA Nephropathy Care
Abdallah Geara, MD
Addressing Food and Nutrition Insecurity in Patients with CKD
Clinician's RoundtableAddressing Food and Nutrition Insecurity in Patients with CKD
Jeanette Andrade, PhD, RDN, LDN, FAND
- advertisement
Steroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Heart MattersSteroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Steve Jackson, PharmD
Robert J. Mentz, MD, FHFSA, FACC
Steve Jackson, PharmD
Robert J. Mentz, MD, FHFSA, FACC
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Brian P. McDonough, MD, FAAFP
Javier Morales, MD, FACP, FACE
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Martha Gulati, MD, MS, FACC, FAHA
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiersSpinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
- advertisement
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
The Convergence"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
Brian P. McDonough, MD, FAAFP
Clement Papadacci, PhD
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
NephrologyIndividualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
Finerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
NephrologyFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
prof. Hiddo Heerspink
